Official website (https://www.regeneron.com/)
OverviewAI-generated
Regeneron Pharmaceuticals is a pharmaceutical company established in 1988. It is an active operating entity based in Tarrytown, New York, United States. The organization is recognized as both a company and a funder.
The firm operates in the pharmaceutical preparations industry, classified under SIC code 2834. It is listed on the Nasdaq exchange under the ticker symbol REGN. Regeneron Pharmaceuticals is included in the Sp 500 collection. Its fiscal year ends on December 31.
Synthesized by Vinony from 25 facts across 5 sources: Wikidata, Firecrawl, SEC EDGAR, ROR, Vinony collections. Generated from structured data (not the Wikipedia text) and checked against those facts — may still contain errors.
Company
REGN- Industry
- Pharmaceutical Preparations
- Exchange
- Nasdaq
- State of incorporation
- NY
- Entity type
- operating
- Latest filing
- 13F-HR · 2026-05-08
- Jurisdiction
- US-NY
- Headquarters
- TARRYTOWN, US
Research organization · ROR
- Type
- Company, Funder
- Founded
- 1988
- Location
- Tarrytown, United States
- Status
- Active
GRID grid.418961.3 · ISNI 0000 0004 0472 2713
Official website
Regeneron | Pushing the Bounds of Science
Discover how Regeneron (NASDAQ: REGN) harmonizes biology and technology to create life-changing medicines. Join our team and explore clinical trials.
regeneron.com →Link to the official site · 6,531 chars · not written by Vinony
Wikidata facts
- Instance of
- public company
- Part of
- Nasdaq-100
- Country
- United States
- Industry
- pharmaceutical industry
- Revenue
- 12172900000
- Stock exchange
- Nasdaq
- Official website
- www.regeneron.com
- Image
- New Eastview office bldg jeh.jpg
Show 6 more facts
- inception
- 1988-00-00
- Commons category
- Regeneron
- social media followers
- 32215
- net profit
- 4338400000
- operating income
- 4738900000
- described at URL
- www.cnbc.com/quotes/REGN
via Wikidata · CC0
~7 min read
Encyclopedic overview
[Skip to Content](https://www.regeneron.com/#mainContent)
Excerpted from Wikipedia’s “Regeneron Pharmaceuticals” article, available under the CC BY-SA 4.0 licence.